Literature DB >> 27562745

Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.

Jessica B McGillen1, Sarah-Jane Anderson2, Mark R Dybul3, Timothy B Hallett2.   

Abstract

BACKGROUND: Advances in HIV prevention methods offer promise to accelerate declines in incidence, but how these methods can be deployed to have the best effect on the heterogeneous landscape and drivers of the pandemic remains unclear. We postulated that use of epidemic heterogeneity to inform the allocation of resources for combination HIV prevention could enhance the impact of HIV funding across sub-Saharan Africa.
METHODS: We developed a compartmental mathematical model of HIV transmission and disease progression by risk group to subnational resolution in 18 countries, capturing 80% of the adult HIV burden in sub-Saharan Africa. Adults aged 15-49 years were grouped by risk of HIV acquisition and transmission, and those older than 50 years were assumed to have negligible risk. For each top-level administrative division, we calibrated the model to historical data for HIV prevalence, sexual behaviours, treatment scale-up, and demographics. We then evaluated four strategies for allocation of prevention funding over a 15 year period from 2016 to 2030, which exploited epidemic differences between subnational regions to varying degrees.
FINDINGS: For a $US20 billion representative expenditure over the 15 year period, scale-up of prevention along present funding channels could avert 5·3 million infections relative to no scale-up. Prioritisation of key populations could avert 3·7 million more infections than present funding channels, and additional prioritisation by within-country geography could avert 400 000 more infections. Removal of national constraints could avert a further 600 000 infections. Risk prioritisation has greater marginal impact than geographical prioritisation across multiple expenditure levels. However, targeting by both risk and geography is best for total impact and could achieve gains of up to three times more than present channels. A shift from the present pattern to the optimum pattern would rebalance resources towards more cost-effective interventions and emerging epidemics.
INTERPRETATION: If domestic and international funders were to align strategically to build an aggregate funding pattern that is guided by the epidemiology of HIV, and particularly by the emerging understanding of local dynamics and epidemic drivers, more cost-effective and impactful HIV prevention investments could be achieved across sub-Saharan Africa. FUNDING: The Bill & Melinda Gates Foundation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27562745     DOI: 10.1016/S2352-3018(16)30051-0

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  35 in total

1.  Modelling of HIV prevention and treatment progress in five South African metropolitan districts.

Authors:  Cari van Schalkwyk; Rob E Dorrington; Thapelo Seatlhodi; Claudia Velasquez; Ali Feizzadeh; Leigh F Johnson
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

2.  PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.

Authors:  Jessica B McGillen; Sarah-Jane Anderson; Timothy B Hallett
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

3.  Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.

Authors:  Stéphanie Blaizot; Helena Huerga; Benjamin Riche; Tom Ellman; Amir Shroufi; Jean-François Etard; René Ecochard
Journal:  BMC Infect Dis       Date:  2017-07-26       Impact factor: 3.090

4.  The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era.

Authors:  Jeffrey W Eaton; Cheryl C Johnson; Simon Gregson
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

5.  Audit of HIV counselling and testing services among primary healthcare facilities in Cameroon: a protocol for a multicentre national cross-sectional study.

Authors:  Frank-Leonel Tianyi; Joel Noutakdie Tochie; Valirie Ndip Agbor; Benjamin Momo Kadia
Journal:  BMJ Open       Date:  2018-03-01       Impact factor: 2.692

6.  Identifying 'corridors of HIV transmission' in a severely affected rural South African population: a case for a shift toward targeted prevention strategies.

Authors:  Frank Tanser; Till Bärnighausen; Adrian Dobra; Benn Sartorius
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

7.  The emerging health impact of voluntary medical male circumcision in Zimbabwe: An evaluation using three epidemiological models.

Authors:  Jessica B McGillen; John Stover; Daniel J Klein; Sinokuthemba Xaba; Getrude Ncube; Mutsa Mhangara; Geraldine N Chipendo; Isaac Taramusi; Leo Beacroft; Timothy B Hallett; Patrick Odawo; Rumbidzai Manzou; Eline L Korenromp
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

8.  Misdiagnosed HIV infection in pregnant women initiating universal ART in South Africa.

Authors:  Nei-Yuan Hsiao; Allison Zerbe; Tamsin K Phillips; Landon Myer; Elaine J Abrams
Journal:  J Int AIDS Soc       Date:  2017-08-29       Impact factor: 5.396

9.  Consequences of a changing US strategy in the global HIV investment landscape.

Authors:  Jessica B McGillen; Alana Sharp; Brian Honermann; Gregorio Millett; Chris Collins; Timothy B Hallett
Journal:  AIDS       Date:  2017-11-28       Impact factor: 4.177

10.  Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning.

Authors:  Gesine Meyer-Rath; Jessica B McGillen; Diego F Cuadros; Timothy B Hallett; Samir Bhatt; Njeri Wabiri; Frank Tanser; Thomas Rehle
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.